DECREASED EXPRESSION OF THE MEMBRANE INHIBITOR OF COMPLEMENT-MEDIATED CYTOLYSIS CD59 ON T-LYMPHOCYTES OF HIV-INFECTED PATIENTS

被引:41
作者
WEISS, L
OKADA, N
HAEFFNERCAVAILLON, N
HATTORI, T
FAUCHER, C
KAZATCHKINE, MD
OKADA, H
机构
[1] HOP BROUSSAIS,SERV IMMUNOL,F-75674 PARIS 14,FRANCE
[2] KUMAMOTO UNIV,SCH MED,KUMAMOTO 860,JAPAN
[3] NAGOYA CITY UNIV,SCH MED,DEPT MOLEC BIOL,NAGOYA,AICHI 467,JAPAN
[4] FUKUOKA UNIV,SCH MED,DEPT MICROBIOL,FUKUOKA 81401,JAPAN
[5] HOP BROUSSAIS,INSERM,U28,F-75674 PARIS 14,FRANCE
关键词
CD59; LYMPHOCYTES; COMPLEMENT; HIV INFECTION;
D O I
10.1097/00002030-199204000-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To study the expression of the membrane inhibitor of complement-mediated cytolysis, CD59, on peripheral blood mononuclear cells (PBMC) from HIV-infected individuals. Methods: CD59 membrane expression was investigated by double immunofluorescent staining on purified PBMC from HIV-infected patients and seronegative controls. Results: CD59 expression was decreased on peripheral blood T-lymphocytes from HIV-infected patients. Decreased expression of CD59 antigen did not correlate with clinical stage of disease. Low CD59 expression on T-lymphocytes was mediated by several mechanisms, including: (1) decrease in number of CD4+ cells which normally express high amounts of the antigen; (2) relative increase in CD8+ cells, more specifically in CD8+ CD57+ cells expressing a low density of the antigen; (3) loss of or decreased CD59 expression on a subpopulation of CD3+ belonging either to the CD4+ or to the CD8+ subset. Decreased CD59 expression was consistently observed on CD8+ lymphocytes. CD59 expression was normal on patient red blood cells, monocytes and B-lymphocytes. Conclusions: HIV infection is associated with a T-cell-specific defect in CD59 membrane expression. Decreased CD59 expression may result in increased susceptibility of T-lymphocytes from HIV-infected patients to complement-mediated lysis.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 17 条
[1]   GENETIC-ANALYSIS OF CR-1 (THE C3B COMPLEMENT RECEPTOR, CD35) EXPRESSION ON ERYTHROCYTES OF HIV-INFECTED INDIVIDUALS [J].
COHEN, JHM ;
GEFFRIAUD, C ;
CAUDWELL, V ;
KAZATCHKINE, MD .
AIDS, 1989, 3 (06) :397-399
[2]   CD59, AN LY-6-LIKE PROTEIN EXPRESSED IN HUMAN LYMPHOID-CELLS, REGULATES THE ACTION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX ON HOMOLOGOUS CELLS [J].
DAVIES, A ;
SIMMONS, DL ;
HALE, G ;
HARRISON, RA ;
TIGHE, H ;
LACHMANN, PJ ;
WALDMANN, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :637-654
[4]   ISOLATION AND CHARACTERIZATION OF A MEMBRANE-PROTEIN FROM NORMAL HUMAN-ERYTHROCYTES THAT INHIBITS REACTIVE LYSIS OF THE ERYTHROCYTES OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].
HOLGUIN, MH ;
FREDRICK, LR ;
BERNSHAW, NJ ;
WILCOX, LA ;
PARKER, CJ .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) :7-17
[5]  
JOUVIN MH, 1987, AIDS, V1, P89
[6]   HEIGHTENED COMPLEMENT SENSITIVITY OF ACQUIRED IMMUNODEFICIENCY SYNDROME LYMPHOCYTES RELATED TO DIMINISHED EXPRESSION OF DECAY-ACCELERATING FACTOR [J].
LEDERMAN, MM ;
PURVIS, SF ;
WALTER, EI ;
CAREY, JT ;
MEDOF, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (11) :4205-4209
[7]   DISPROPORTIONATE EXPANSION OF A MINOR T-CELL SUBSET IN PATIENTS WITH LYMPHADENOPATHY SYNDROME AND ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
LEWIS, DE ;
PUCK, JM ;
BABCOCK, GF ;
RICH, RR .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :555-559
[8]   HUMAN PROTECTIN (CD59), AN 18-20-KD HOMOLOGOUS COMPLEMENT RESTRICTION FACTOR, DOES NOT RESTRICT PERFORIN-MEDIATED LYSIS [J].
MERI, S ;
MORGAN, BP ;
WING, M ;
JONES, J ;
DAVIES, A ;
PODACK, E ;
LACHMANN, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :367-370
[9]   20KDA HOMOLOGOUS RESTRICTION FACTOR OF COMPLEMENT RESEMBLES T-CELL ACTIVATING PROTEIN [J].
OKADA, H ;
NAGAMI, Y ;
TAKAHASHI, K ;
OKADA, N ;
HIDESHIMA, T ;
TAKIZAWA, H ;
KONDO, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (03) :1553-1559
[10]  
OKADA N, 1989, J IMMUNOL, V143, P2262